Skip to main content
RIGL logo
RIGL
(NASDAQ)
Rigel Pharmaceuticals, Inc.
$27.53-- (--)
Loading... - Market loading

Rigel Pharmaceuticals (RIGL) Stock Price & Financial Analysis

Rigel Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.75 - $27.62
52-Week High$52.24
52-Week Low$15.50
Open$26.83
Volume186.45K
Average Volume (3M)186.45K
Market Cap518.67M
Shares Outstanding18.84M
P/E Ratio (TTM)1.41
Forward P/E0.71
Price to Sales (P/S)1.76
Price to Book (P/B)1.32
EV/EBITDA4.15
Revenue (TTM)294.28M
Net Income (TTM)367.02M
EPS (TTM)$19.48
Profit Margin124.72%
Operating Margin42.63%
Return on Equity (ROE)93.75%
Debt to Equity0.14
50-Day MA$31.80
200-Day MA$32.98
52-Week Change60.35%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Rigel Pharmaceuticals

What is the current stock price for RIGL?

As of the latest trading session, RIGL stock trades at $27.53. The 52-week range is $15.50–$52.24, with a day range of $26.75–$27.62.

What is the P/E ratio for RIGL?

Rigel Pharmaceuticals's trailing P/E ratio is 1.4, meaning investors pay $1.4 for every $1 of annual earnings. The forward P/E is 0.7, reflecting analyst expectations for future earnings. Rigel Pharmaceuticals operates in the Healthcare sector.

Does RIGL pay dividends?

Rigel Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RIGL?

Analyst ratings and recommendations for RIGL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of RIGL?

Rigel Pharmaceuticals's market capitalization is $518.7M, classifying it as a small-cap company. Rigel Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.